Not all toxin types, concentrations provide the same results
February 18, 2020
Understanding differences among preparations and dilutions of botulinum toxin type A can improve clinical practice, according to industry experts.
Whitney J. Palmer
Systemic option for squamous cell carcinoma
January 20, 2020
A new systemic medication option offers promising results for patients with high-risk squamous cell carcinoma for whom surgery has not worked, says this expert.
Moisturizers offer easy, low-cost option for kids with atopic dermatitis
January 16, 2020
Anneke Andriessen, Ph.D. discusses research that suggests controlling symptoms with moisturizers can be an important — and inexpensive — prevention and treatment tactic for pediatric patients with atopic dermatitis.
A basis for standardizing care for patients with atopic dermatitis
January 10, 2020
As one of the most common dermatological conditions of childhood, atopic dermatitis affects between 10% and 20% of pediatric patients.
![CBD skincare](https://www.dermatologytimes.com/sites/default/files/styles/trc_article_348x228/public/CannabisCream_AdobeStock_RuggedCoast_232035444_1.jpeg?itok=elAKZmHi "<p>"My advice to providers who strive to maintain the highest standard of ethics is to be aware there aren’t any products out there right now that really deliver," says Daniel Siegel, M.D., M.S. <small>(RuggedCoast - stock.adobe.com)</small></p>")
Are CBD skincare products effective?
January 8, 2020
A variety of topical CBD products are becoming increasingly available to patients, but do they actually work? These experts believe more research is needed to create CBD-containing dermatology products that can effectively treat skin disorders.
Patients don't talk about hyperhidrosis
November 13, 2019
Many patients living with hyperhidrosis do so silently, meaning the condition is often left untreated. It's up to dermatologists start the conversation about available treatments when they notice patients’ symptoms, say this expert.
Clinical trials offer hope for hidradenitis suppurativa patients
November 13, 2019
Clinical trials investigating the efficacy of biologics in treating this condition at Stage 2 and Stage 3 are growing in number and should be considered a front-line treatment option, says this expert.
Methods to optimize filler outcomes, patient satisfaction
October 20, 2019
Dr. Susan Weinkle offers tips to minimize discomfort, which plays a large role in the patient’s perception of outcome.
Important developments in the treatment of SCC
October 19, 2019
Dr. Scott Dinehart discusses two newer methods for attacking squamous cell carcinoma, which he says are critical to know.
Quality of life suffers in breast cancer patients with radiodermatitis
October 18, 2019
Radiodermatitis affects approximately 95% of all patients who receive radiation therapy for cancer - many of who are women undergoing breast cancer treatment. A recent study has found that developing the condition has a significant and detrimental impact on breast cancer patients' overall quality-of-life.
